Virinchi Limited has informed the Exchange regarding 'Allotment of Convertible Equity Warrants'.
VIRINCHI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 0.6 pts less than its Software Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Virinchi Limited has allotted 86,00,000 (86 lakh) convertible equity warrants to Vivo Bio Tech Limited, a promoter group entity, at an issue price of Rs. 28 per warrant (Rs. 10 face value + Rs. 18 premium). This is part of a larger approval for 2,00,00,000 (2 crore) warrants passed at an EGM on November 15, 2025. The company has received 25% of the consideration (Rs. 7 per warrant), totaling Rs. 6.02 crore, with the balance 75% (Rs. 21 per warrant) due upon conversion. Warrants are convertible into equal equity shares within 18 months; if not exercised, they will lapse and the 25% paid amount will be forfeited. Assuming full conversion, promoter group holding will rise from 37.51% to 42.34%, an increase of about 4.83 percentage points. There is no immediate change in paid-up share capital until conversion occurs.
The allotment strengthens the promoter group's stake in Virinchi, signaling promoter commitment to the company. However, no fresh equity capital is raised yet—only Rs. 6.02 crore received now—and potential dilution of public shareholders by about 4.83% looms if all warrants are converted within 18 months.